company background image
SMSLIFE logo

SMS Lifesciences India NSEI:SMSLIFE Lagerbericht

Letzter Preis

₹1.37k

Marktkapitalisierung

₹4.1b

7D

-2.9%

1Y

172.1%

Aktualisiert

04 Nov, 2024

Daten

Finanzdaten des Unternehmens

SMS Lifesciences India Limited Wettbewerber

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für SMS Lifesciences India
Historische Aktienkurse
Aktueller Aktienkurs₹1,366.70
52-Wochen-Hoch₹1,749.65
52-Wochen-Tief₹487.05
Beta0.74
11 Monat Veränderung-6.30%
3 Monate Veränderung55.83%
1 Jahr Veränderung172.14%
33 Jahre Veränderung57.91%
5 Jahre Veränderung371.85%
Veränderung seit IPO913.50%

Aktuelle Nachrichten und Updates

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Recent updates

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Aug 01
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Jun 13
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

Feb 10
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Jan 05
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

Sep 23
Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

Sep 07
SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

Aug 24
SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 16
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 02
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

Jun 03
SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

May 13
With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Nov 23
SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Jun 21
Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Feb 22
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 04
SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Nov 27
Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Nov 24
Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Aktionärsrenditen

SMSLIFEIN PharmaceuticalsIN Markt
7D-2.9%2.0%1.8%
1Y172.1%58.6%36.8%

Rendite im Vergleich zur Industrie: SMSLIFE exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.

Rendite vs. Markt: SMSLIFE exceeded the Indian Market which returned 36.8% over the past year.

Preisvolatilität

Is SMSLIFE's price volatile compared to industry and market?
SMSLIFE volatility
SMSLIFE Average Weekly Movement10.0%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.4%
10% least volatile stocks in IN Market4.0%

Stabiler Aktienkurs: SMSLIFE's share price has been volatile over the past 3 months compared to the Indian market.

Volatilität im Zeitverlauf: SMSLIFE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
1990574Talluri Veera Venkata Murthywww.smslife.in

SMS Lifesciences India Limited produziert und vertreibt pharmazeutische Wirkstoffe (APIs) und Zwischenprodukte in Indien. Das Unternehmen bietet APIs in verschiedenen therapeutischen Bereichen an, z. B. gegen Geschwüre, erektile Dysfunktion, Gicht, Anästhesie, Infektionskrankheiten, Fettleibigkeit, Pilzerkrankungen, Krämpfe, Brechreiz, Augenkrankheiten, Würmer und Antiemetika. Darüber hinaus entwickelt das Unternehmen Wirkstoffe in den Bereichen Antidepressiva, Antipsychotika, Antihypertensiva, Tierarzneimittel, Antivirenmittel und Antikoagulanzien.

SMS Lifesciences India Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von SMS Lifesciences India im Vergleich zum Marktanteil des Unternehmens?
SMSLIFE grundlegende Statistiken
Marktanteil₹4.13b
Gewinn(TTM)₹178.86m
Umsatz(TTM)₹3.24b

23.1x

Kurs-Gewinn-Verhältnis

1.3x

Kurs-Umsatz-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
SMSLIFE Gewinn- und Verlustrechnung (TTM)
Einnahmen₹3.24b
Kosten der Einnahmen₹2.11b
Bruttogewinn₹1.13b
Sonstige Ausgaben₹948.83m
Umsatz₹178.86m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)59.16
Bruttomarge34.82%
Nettogewinnspanne5.52%
Schulden/Eigenkapital-Verhältnis52.0%

Wie hat sich SMSLIFE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.1%

Aktuelle Dividendenrendite

5%

Ausschüttungsquote